BlackRock Amends Evolent Health Stake, Maintains Passive Position
Ticker: EVH · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1628908
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still owns a chunk of Evolent Health, but they're just holding, not shaking things up.**
AI Summary
BlackRock, Inc. filed an amended Schedule 13G/A on January 26, 2024, indicating its ownership of Class A Common Stock in Evolent Health, Inc. as of December 31, 2023. This amendment, number 5, shows BlackRock's continued significant passive investment in Evolent Health. For investors, this means a major institutional investor maintains a stake, which can signal confidence in the company's long-term prospects, but it's a passive holding, so BlackRock isn't actively trying to influence management.
Why It Matters
This filing confirms BlackRock's ongoing, substantial, but passive investment in Evolent Health, which can be a positive signal for current and prospective shareholders regarding institutional confidence.
Risk Assessment
Risk Level: low — This filing indicates a passive investment by a large institution, which generally doesn't introduce significant new risks or changes to the company's operations.
Analyst Insight
An investor should note BlackRock's continued passive stake as a sign of institutional presence, but understand it doesn't imply active management involvement or an impending strategic move. Further research into Evolent Health's fundamentals and BlackRock's overall investment strategy would be prudent.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person and institutional investor
- Evolent Health, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, indicating a change or update to a previously filed beneficial ownership report by a passive investor.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., identified by CIK 0001364742 and located at 50 Hudson Yards, New York, NY.
What is the subject company whose securities are being reported?
The subject company is Evolent Health, Inc., identified by CIK 0001628908 and located at 800 North Glebe Rd, Suite 500, Arlington, VA.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Class A Common Stock of Evolent Health, Inc. is 30050B101.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as stated in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding Evolent Health, Inc. (EVH).